CAPTOPRIL OR FRUSEMIDE IN DRUG-RESISTANT HYPERTENSION - REPLY

A. B. Atkinson; J. J. Brown; A.F. Lever; Jis Robertson; Sir Nicholas White; B Rajagopalan; Hameed A. Yahaya; Ledingham Jgg.

Letter1980

CAPTOPRIL OR FRUSEMIDE IN DRUG-RESISTANT HYPERTENSION?

B. Deibjerg Kristensen, Jesper Lundsby Skov, A. B. Atkinson, J. J. Brown, A.F. Lever, J. I. S. Robertson, Sir Nicholas White, B. Rajagopalan, H Yahaya, J.G.G. Ledingeam

The Lancet

Article1980

CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSION

Sir Nicholas White, H Yahaya, B. Rajagopalan, J Ledingham

The Lancet

Article2004

Monitoring antimalarial drug efficacy - Reply

Mayfong Mayxay, Paul N. Newton, Maniphone Khanthavong, P Tiengkham, Rattanaxay Phetsouvanh, Samlane Phompida, A Brockman, Sir Nicholas White

Clinical Infectious Diseases

Letter2015

Global extent of chloroquine-resistant Plasmodium vivax – Authors' reply

Ric N. Price, Lorenz von Seidlein, Neena Valecha, François Nosten, J. Kevin Baird, Sir Nicholas White

The Lancet Infectious Diseases

Article2007

Risks associated with drug-eluting stents – Authors' reply

Joost Daemen, Peter Wenaweser, Stephan Windecker, Patrick W. Serruys

The Lancet

CAPTOPRIL OR FRUSEMIDE IN DRUG-RESISTANT HYPERTENSION - REPLY

Abstract

Discussion(0)

Related publications

CAPTOPRIL OR FRUSEMIDE IN DRUG-RESISTANT HYPERTENSION?

CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSION

Monitoring antimalarial drug efficacy - Reply

Global extent of chloroquine-resistant Plasmodium vivax – Authors' reply

Risks associated with drug-eluting stents – Authors' reply